Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis
JAAD International(2021)
Abstract
Apremilast is a robust antipsoriatic drug for which the drug survival is not strongly influenced by most patient- or disease-related factors except age. Drug survival is significantly shorter in patients younger than 40 years.
MoreTranslated text
Key words
apremilast,drug survival,psoriasis
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined